Standard Treatments: Rebuilding the Drainage System
At a Glance
For adults with symptomatic, completely blocked acquired tear ducts, dacryocystorhinostomy, or DCR, is usually the standard treatment. It creates a new drainage opening between the tear sac and nose; external and endoscopic approaches are both effective.
When chronic inflammation and scar tissue have completely blocked your tear duct, the most effective solution is often to create a brand-new drainage pathway. This definitive surgical treatment is known as a Dacryocystorhinostomy (DCR).
Because the original duct is too scarred to simply “unclog,” a DCR bypasses the blockage entirely by creating a new opening between the tear sac and the inside of your nose [1][2]. This is considered the standard of care for treating symptomatic, complete acquired tear duct obstruction in adults.
Comparing Your Surgical Options
There are two primary ways to perform a DCR. Both are highly effective, with functional success rates typically ranging around 88% to 92%, though exact outcomes depend on your specific anatomy, whether success means an open ostium or symptom relief, and how long you are followed [1][3].
External DCR
In this traditional approach, the surgeon makes a small incision (about 10–15 mm) on the side of your nose where your glasses might sit [4].
- Pros: It allows the surgeon the best direct view of the anatomy and has been the standard of care for decades [5].
- Cons: It leaves a small visible scar, though this typically fades significantly over time [4].
Endoscopic DCR
This approach is performed entirely through the nostrils using a tiny camera (endoscope) and specialized tools. There is no skin incision [1].
- Pros: There is no external scar, and recovery is often slightly faster [4][6].
- Cons: It can be more technically challenging for the surgeon if your nasal passages are very narrow, and some studies suggest a slightly higher risk of minor intraoperative hemorrhage [6].
The Debate Over Silicone Stents
During a DCR, your surgeon may place a thin, flexible silicone stent (a tiny tube) through the new opening to keep it from closing as it heals [7]. Whether or not to use a stent is a topic of ongoing debate among specialists:
- Potential Benefits: Some meta-analyses suggest that stenting may slightly improve anatomical success (ensuring the hole stays open). It is often utilized for patients with canalicular disease, trauma, or revision surgery [7][8].
- Potential Downsides: Stents can sometimes cause tube displacement, punctal or nasal irritation, infection, or the growth of granulation tissue (extra scar-like tissue) that can actually block the duct further [7].
- Long-Term Results: Many randomized trials have found no significant difference in long-term tearing symptoms between patients who had a stent and those who did not [9][10].
Your surgeon will decide whether a stent is right for you based on the size of your tear sac and specific clinical findings [11][2].
What to Expect: Surgical Risks and Recovery
DCR is generally a very safe outpatient surgery, performed under either local or general anesthesia. However, as with any surgery, you should be aware of the risks:
- Common: Bruising around the eye, expected nasal bleeding for the first few days, and temporary nasal congestion.
- Potential Risks: Infection, displacement of the stent, or restenosis (recurrence of the blockage, which may require a revision surgery).
- Rare Risks: Severe bleeding, anesthesia risks, or injury to surrounding orbital structures.
Why Less Invasive Options Are Selected Carefully
Procedures like probing or balloon dacryoplasty (inflating a tiny balloon to stretch the duct) are highly effective in babies, but have notably lower success rates for adults with complete blockages [1]. However, they may still be considered for selected partial obstructions, canalicular disease, or particular anatomy [12].
Factors That Can Affect Your Outcome
While DCR is highly successful, certain factors can make the surgery more complex or increase the risk of the blockage returning:
- Canalicular Disease: If the very small tubes that lead into the tear sac are also blocked, a standard DCR may not be enough to stop the tearing [13][14].
- Small Lacrimal Sac: A very small or shrunken tear sac can make it harder to create a durable new drainage hole [11][14].
- History of Infection: Patients who have had severe infections of the tear sac (dacryocystitis) or who have blockages in both eyes may have a slightly higher risk of recurrence [15].
- Secondary Causes: If your blockage was caused by radiation therapy or radioactive iodine (SANDO), the success rates may be slightly lower due to more extensive tissue scarring [16].
Common questions in this guide
What surgery is usually used for a completely blocked tear duct in an adult?
Is external or endoscopic DCR better for tear duct blockage?
Will I need a silicone stent during DCR surgery?
What should I expect while recovering from DCR surgery?
What happens if my eye still waters after DCR?
Can probing or balloon treatment fix an acquired blocked tear duct?
Get notified when new evidence is published on acquired tear duct stenosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Best treatments available for distal acquired lacrimal obstruction: A systematic review and meta-analysis.
Vinciguerra A, Nonis A, Giordano Resti A, et al.
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 2020; (45(4)):545-557 doi:10.1111/coa.13551.
PMID: 32304619 - 2
Endoscopic dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction: A systematic review and pooled analysis of powered vs. non-powered technique.
Daloiso A, Gaudioso P, Negrisolo M, et al.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2026; (283(5)):2827-2847 doi:10.1007/s00405-025-09961-1.
PMID: 41786947 - 3
Trends and Outcomes of Endoscopic Versus External Dacryocystorhinostomy: A 20-year Retrospective Multi-Institutional Analysis.
Davila N, McLaughlin SA, Pradeep T, et al.
Ophthalmic plastic and reconstructive surgery 2026; (42(2)):196-201 doi:10.1097/IOP.0000000000003049.
PMID: 40865166 - 4
Clinical Trial to Compare Success Rate of Endonasal Dacryocystorhinostomy and External Dacryocystorhinostomy for Treatment of Primary Acquired Nasolacrimal Duct Obstruction.
Khatri MS, Kharaya A
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India 2022; (74(Suppl 2)):1266-1273 doi:10.1007/s12070-020-02352-4.
PMID: 36452658 - 5
Modified External Dacryocystorhinostomy in Primary Acquired Nasolacrimal Duct Obstruction.
Sharma HR, Sharma AK, Sharma R
Journal of clinical and diagnostic research : JCDR 2015; (9(10)):NC01-5 doi:10.7860/JCDR/2015/15940.6624.
PMID: 26557549 - 6
External versus Endoscopic Dacryocystorhinostomy for Primary Acquired Nasolacrimal Duct Obstruction.
Rajabi MT, Shahraki K, Nozare A, et al.
Middle East African journal of ophthalmology 2022; (29(1)):1-6 doi:10.4103/meajo.meajo_238_21.
PMID: 36685339 - 7
Safety and efficacy of silicone intubation compared to standard techniques in endoscopic dacryocystorhinostomy: a systematic review and meta-analysis.
Dar A, Jalal AA, Ibrahim M, et al.
International ophthalmology 2026; (46(1)).
PMID: 42455412 - 8
Meta-analysis of randomized controlled trials in dacryocystorhinostomy with and without silicone intubation.
Ing EB, Bedi H, Hussain A, et al.
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2018; (53(5)):466-470 doi:10.1016/j.jcjo.2017.12.006.
PMID: 30340712 - 9
Prospective, randomised clinical trial on the necessity of using a silicone intubarium in the context of endonasal-endoscopic dacryocystorhinostomy (EN-DCR) in patients with postsaccal lacrimal duct stenosis.
Bahner L, Zebralla V, Dietz A, et al.
International ophthalmology 2024; (44(1)):293 doi:10.1007/s10792-024-03205-7.
PMID: 38940962 - 10
Randomized Controlled Trial on Silicone Intubation in Endoscopic Mechanical Dacryocystorhinostomy (SEND): An 11-year Outcome Report.
Chan KK, Yung GW, Chee ASH, et al.
Seminars in ophthalmology 2025; (40(1)):54-60 doi:10.1080/08820538.2024.2385391.
PMID: 39246013 - 11
Predictors of nasolacrimal duct intubation failure for primary acquired nasolacrimal duct obstruction: a computed tomography-dacryocystography (CT-DCG) study.
Wang W, Lin T, Gong L, Wang Y
Quantitative imaging in medicine and surgery 2024; (14(10)):7229-7236 doi:10.21037/qims-24-519.
PMID: 39429569 - 12
[Minimally invasive therapy for nasolacrimal duct obstructions].
Emmerich KH, Lang M, Meyer-Rüsenberg H
Klinische Monatsblatter fur Augenheilkunde 2024; (241(12)):1361-1371 doi:10.1055/a-2375-0128.
PMID: 39255814 - 13
Endoscopic dacryocystorhinostomy as treatment for lower lacrimal pathway obstructions in adults: Review article.
Penttilä E, Smirnov G, Tuomilehto H, et al.
Allergy & rhinology (Providence, R.I.) 2015; (6(1)):12-9 doi:10.2500/ar.2015.6.0116.
PMID: 25860166 - 14
Surgical outcomes of external dacryocystorhinostomy and risk factors for functional failure: a 10-year experience.
Lee MJ, Khwarg SI, Kim IH, et al.
Eye (London, England) 2017; (31(5)):691-697 doi:10.1038/eye.2016.308.
PMID: 28085144 - 15
Role of paranasal abnormalities and systemic inflammation on primary acquired nasolacrimal duct obstruction.
Sevimli N, Aydın Kurna S, Çakır M, Akkaya S
Journal of ophthalmic inflammation and infection 2024; (14(1)):38 doi:10.1186/s12348-024-00416-y.
PMID: 39143354 - 16
Outcomes of Endoscopic Dacryocystorhinostomy in Secondary Acquired Nasolacrimal Duct Obstruction: A Case-Control Study.
Sweeney AR, Davis GE, Chang SH, Amadi AJ
Ophthalmic plastic and reconstructive surgery 2018; (34(1)):20-25 doi:10.1097/IOP.0000000000000841.
PMID: 27997463
This page is for educational purposes only and does not constitute medical advice. Your ophthalmic surgeon should recommend the DCR approach and stent plan based on your anatomy, symptoms, and medical history.